cancer clinical trials in tennessee
Sarah Cannon Research Institute
Nashville, Tennessee 37203 B-cell Follicular Lymphoma, B-cell Marginal Zone Lymphoma, Diffuse Large B-cell Lymphoma, B-cell Mantle Cell Lymphoma, B-cell Small Lymphocytic Lymphoma (SLL), B-Cell Chronic Lymphocytic Leukemia (B-CLL), Multiple Myeloma, Waldenstrom's Macroglobulinemia, Noncutaneous Peripheral T-cell Lymphoma Not Otherwise Specified (PTCL-NOS), Angioimmunoblastic T-cell Lymphoma (AITL), Anaplastic Large Cell Lymphoma, Enteropathy Associated T-cell Lymphoma (EATCL), NK Lymphoma (NKL)
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Adrenocortical Tumor
|
ImClone Investigational Site
Memphis, Tennessee 38104 Breast Cancer
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Acute Myeloid Leukemia
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Thyroid Cancer
|
Chattanooga Oncology and Hematology Associates
Trial Locations Chattanooga Oncology and Hematology Associates Sarah Cannon Research Institute Non Small Cell Lung Cancer
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
|
East Tennessee Children's Hospital
Knoxville, Tennessee 37901 Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
|
Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza
Trial Locations Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza Tennessee Oncology Dept. of Centennial Medical Myelogenous Leukemia, Chronic
|
East Tennessee Childrens Hospital
Knoxville, Tennessee 37916 Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
GSK Investigational Site
Germantown, Tennessee 38138 Carcinoma, Renal Cell
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Solid Tumor
|
Division of Hematology and Oncology Vanderbilt University
Nashville, Tennessee 37232 Mantle Cell Lymphoma
|
GSK Investigational Site
Germantown, Tennessee 38138 WT1-positive Acute Myeloid Leukemia, Leukaemia, Myelocytic, Acute
|
1200.36.0020 Boehringer Ingelheim Investigational Site
Memphis, Tennessee Glioma
|
ImClone Investigational Site
Memphis, Tennessee 38104 Metastatic Breast Cancer
|
Sarah Cannon Research Institute
Trial Locations Sarah Cannon Research Institute Vanderbilt-Ingram Cancer Ctr Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
|
Tennessee Oncology, PLLC
Clarksville, Tennessee 37043 Renal Cell Carcinoma
|
Sibyl Wray Neurology, PC
Trial Locations Sibyl Wray Neurology, PC Vanderbilt University Primary Progressive Multiple Sclerosis
|
T C Thompson Children's Hospital
Trial Locations T C Thompson Children's Hospital East Tennessee Childrens Hospital St. Jude Children's Research Hospital Vanderbilt-Ingram Cancer Center Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
University of Tennessee, Boston Baskin Cancer Group, PLC
Memphis, Tennessee 38104 Mantle Cell Lymphoma
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Neuroblastoma, Melanoma, Osteosarcoma
|
University of Tennessee Cancer Institute
Memphis, Tennessee 38103 Prostatic Neoplasms
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center - Cool Springs Vanderbilt-Ingram Cancer Center at Franklin Head and Neck Cancer
|
Vanderbilt-Ingram Cancer Center - Cool Springs
Trial Locations Vanderbilt-Ingram Cancer Center - Cool Springs Vanderbilt-Ingram Cancer Center at Franklin Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
|
Tennessee Oncology
Nashville, Tennessee 37203 Refractory Solid Tumors
|
St. Jude Children's Research Hospital
Memphis, Tennessee 38105-2794 Cancer
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Memphis, Tennessee 38138 Non-small Cell Lung Cancer
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center - Cool Springs Vanderbilt-Ingram Cancer Center at Franklin Lymphoma
|
Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
Trial Locations Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center U.T. Medical Center Cancer Institute Malignant Mesothelioma
|
HIFU Site: Urology Associates
Nashville, Tennessee 37209 Prostate Cancer
|
East Tennessee Childrens Hospital
Trial Locations East Tennessee Childrens Hospital St. Jude Children's Research Hospital Vanderbilt-Ingram Cancer Center Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Tennessee Cancer Institute
Trial Locations University of Tennessee Cancer Institute The West Clinic Breast Cancer
|